logo
Is this the oldest burial site in the world? Archaeologists find human remains carefully arranged in bat-infested cave

Is this the oldest burial site in the world? Archaeologists find human remains carefully arranged in bat-infested cave

Scottish Sun4 days ago
A team of students will take years to fully excavate the Stone Age site
BATCAVE BURIAL Is this the oldest burial site in the world? Archaeologists find human remains carefully arranged in bat-infested cave
Click to share on X/Twitter (Opens in new window)
Click to share on Facebook (Opens in new window)
ARCHAEOLOGISTS may have found the oldest burial site in the world - after discovering carefully arranged human remains dating back 100,000 years.
Boffins made the groundbreaking find at a bat-infested cave in Israel - where they unearthed ancient yet well-preserved bodies in neat formations.
Sign up for Scottish Sun
newsletter
Sign up
8
Archaeologists may have found the oldest burial site in the world
Credit: AP
8
Boffins have discovered carefully arranged human remains dating back 100,000 years
Credit: AP
8
Professor of Archaeology Yossi Zaidner (C) works in Tinshemet Cave
Credit: AP
8
The jaw-dropping discovery may mark itself as the oldest burial site in the world.
Archaeologists were particularly interested in objects found beside the remains - which may have been used in ceremonies or rituals to honour the dead.
These pieces of evidence could shed light on how ancient ancestors thought about the afterlife.
One of the directors of the cutting-edge excavation Yossi Zaidner hailed the find as "an amazing revolutionary innovation for our species".
READ MORE WORLD NEWS
ANCIENT FIND Lost city from 3,500-years-ago home to the Americas' oldest civilization found
The discoveries at Tinshemet Cave in central Israel were published in an academic journal earlier this year.
They build on previous discoveries in northern Israel and add to a growing understanding of the origins of human burial.
Researchers were working at Tinshemet since 2016, and they claim to have unearthed the remains of five early humans that date to around 110,000 to 100,000 years ago.
The fascinating skeletal remains were found arranged in fetal positions in a deep pit.
Objects found around them included basalt pebbles, animal remains or fragments of ochre.
Since these curious objects had no use for daily life, scientists believe they were part of burying rituals.
Incredible ancient lost city from 3,500-years-ago home to the Americas' oldest civilization uncovered in Peru
Tinshemet Cave is located in the hills of central Israel - and is filled with squeaking fruit bats.
Zaidner said there is stone mound in and outside the cave - which he called one of the three or four most important sites for study of human evolution and behaviour during the Paleolithic time.
The Paleolithic era is known as the Stone Age because of the onset of stone tools.
It lasted from as early as 3.3 million years ago until around 10,000 years ago.
Tinshemet Cave is from the Middle Paleolithic era, roughly between 250,000 to 30,000 years ago.
Findings from the extraordinary cave were published in March - with a key discovery being the remains of five early humans.
Researchers are now using hand chisels and delicate, pen-sized pneumatic drills that resemble dental tools, to pick apart their findings.
But they will need many more years to fully excavate the site.
8
Th full excavation will take years
Credit: AP
8
Researchers found fascinating objects near the remains
Credit: AP
A dozen archaeology students have spread out across the site, painstakingly documenting and removing each fragment of tool, object or bone.
Archaeology professor Christian Tryon said: "Tinshemet is exceptionally important to archaeologists because the local climate preserved the bones, tools, and ornaments in good condition, unlike many other parts of the world where these items were lost to time."
The high quality of preservation is said to be because of ash from frequent fires, possibly from rituals.
The large amount of ash mixed with rainfall and Israel's acidic limestone, created optimal conditions for preservation, the professor added.
One skeleton was in such good condition that archaeologists could see how the skeleton's fingers were interwoven, with their hands clasped beneath their head.
Tyron said the new finds at Tinshemet Cave back up earlier digs at Skhul and Qafzeh caves, showing early humans were starting to bury their dead more widely.
The older sites, dug decades ago, left many questions, but Tinshemet's precise dating confirms the pattern.
Some experts even argue burials may go back 200,000 years - citing the Homo naledi in South Africa.
But many scientists doubt the claims, saying there is not enough evidence and calling the ideas controversial.
8
The fruit bat-infested Tinshemet Cave is located in central Israel
Credit: AP
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Elon Musk's Neuralink brain chip lets paralysed woman write her name after 20 YEARS ‘just by thinking'
Elon Musk's Neuralink brain chip lets paralysed woman write her name after 20 YEARS ‘just by thinking'

Scottish Sun

time6 hours ago

  • Scottish Sun

Elon Musk's Neuralink brain chip lets paralysed woman write her name after 20 YEARS ‘just by thinking'

Once inserted in the participants brain, the chip allows users to control digital interfaces through brain signals alone BRAIN TRAINING Elon Musk's Neuralink brain chip lets paralysed woman write her name after 20 YEARS 'just by thinking' Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) A PARALYSED woman has written her name for the first time in 20 years using only her mind. Audrey Crews is one of the participants in Elon Musk's Neuralink trial, having had a computer chip installed in her brain. Sign up for Scottish Sun newsletter Sign up 4 The telepathic powers were granted to Crews as part of the company's PRIME study, which aims to test BCI chips in human subjects Credit: X / @NeuraNova9 4 Once inserted in the participants' brain, the chip allows users to control digital interfaces through brain signals alone Credit: Getty The chip, or brain-computer interface (BCI) as Neuralink calls it, connects Crews' brain to a computer and allows her to control the mouse on the screen. Crews lost movement at age 16, and is the first woman to receive the implant. Sharing the moment on X (formerly Twitter), Crews posted: 'I tried writing my name for the first time in 20 years. I'm working on it. Lol #Neuralink.' In shaky writing on her laptop screen is the word 'Audrey'. Musk, co-founder of Neuralink, replied to the post, saying: "She is controlling her computer just by thinking. Most people don't realise it is possible." It's hard for most people to imagine what it would be like writing - or even gaming - using only your mind. But Crews described it as "like writing your name in your head". The telepathic powers were granted to Crews as part of the company's PRIME study, which aims to test BCI chips in human subjects. Once inserted in the participants' brain, the chip allows users to control digital interfaces through brain signals alone. In a follow-up post, Crews explained: 'It was brain surgery, they drilled a hole in my skull and placed 128 threads into my motor cortex. 'The chip is about the size of a quarter.' While Musk hopes the technology will one day be used to help quadriplegics walk again, the company is still far away from this end result. What is Neuralink? Here's what you need to know... Neuralink is a project that aims to embed computer chips in people's brains The idea is to give humans hyper-intelligence by merging them with artificial intelligence Tiny threads thinner than a human hair would pump information into your noggin It would work a bit like an internet cable, transmitting data in and out at high speeds As well as making us smarter, the project promises to merge us with computers and phones That means you could control your gizmos with your brain Neuralink is bankrolled by billionaire entrepreneur Elon Musk He's previously said the tech could save us from a machine uprising in future The device does not yet restore physical mobility. 'I also want to clarify this implant will not allow me to walk again or regain movement," said Crews. "It's strictly for telepathy only.' Crews is one of seven paralysed patients undergoing the trial. 4 How Neuralink works

‘Game-changing' Alzheimer's drug could STOP disease in its tracks – as the ‘most powerful weapon' against condition yet
‘Game-changing' Alzheimer's drug could STOP disease in its tracks – as the ‘most powerful weapon' against condition yet

Scottish Sun

time7 hours ago

  • Scottish Sun

‘Game-changing' Alzheimer's drug could STOP disease in its tracks – as the ‘most powerful weapon' against condition yet

Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) A NEW "game-changing" drug could stop the progression of Alzheimer's disease, early trials suggest. Scientists say the treatment - called trontinemab - could be the most powerful weapon yet against dementia, as they look into giving the drug to people with no symptoms in the hopes of preventing disease. Sign up for Scottish Sun newsletter Sign up 1 Trontinemab is formulated to bypass the blood-brain barrier to target plaques clogging up brain cells Credit: Getty Phase two trial results for trontinemab were presented at he Alzheimer's Association International Conference in Toronto. Researchers said the drug seemed to clear plaques - the abnormal build-up of proteins around brain cells that cause damage and disrupt function - quicker than other drugs licensed to treat Alzheimer's. Trontinemab cleared out plaques and eliminated visible signs of the the disease within 28 weeks for nine out of 10 patients. Drug-maker Roche is now conducting another trial to see if plaque clearance also improves patients' memory. The 18-month study includes 1,600 people, the Telegraph reported. Separate research will examine whether the drug could be given to people without any signs of dementia, just as statins are used to ward off heart disease. Experts hope the drug could stop patients from developing dementia symptoms at all, if it is given early enough. They described the findings so far as 'very promising', suggesting that the drug was much more powerful than existing ones while leading to fewer side effects - as it was able to clear plaques better within seven months that other drugs can in 18 months. Roche's chief medical officer Levi Garraway said: 'Alzheimer's disease represents one of the greatest challenges in healthcare today and tackling it requires early detection and effective therapeutics. 'Trontinemab is designed to target a key driver of Alzheimer's disease biology more effectively in the brain. Common painkiller used for back pain ups risk of dementia by 29%, scientists warn "Combining new treatment avenues with advanced diagnostics may enable earlier and potentially more effective intervention. "With plans for phase three trials in both early symptomatic and pre-clinical Alzheimer's disease, we are advancing science with the goal of delaying - and ultimately preventing - progression of this devastating condition.' Prof Sir John Hardy, the chairman of molecular biology of neurological disease at University College London's Institute of Neurology told the Telegraph trontinemab could be 'game-changing'. The scientist, who was the first to identify the role of amyloid plaques in Alzeheimer's, said: 'This is absolutely great news. "It sucks the plaque out of the brain really quickly, much faster than we have seen with lecanemab or donanemab.' Both are Alzheimer's drugs approved for used in the UK, which target amyloid proteins in the brain to slow disease progression. However, neither treatment is offered on the NHS, as the National Institute for Health and Care Excellence (Nice) deemed them too expensive - in large part because patients need frequent scans to monitor for brain swelling and bleeds. Prof Hardy added: 'There is no doubt [trontinemab] could be game-changing. "We hope that if we can use these drugs to people early, we can halt the progression of disease, even before people have symptoms. "Now we need to see the size of the clinical effect. 'These results show it is much faster and safer than previous drugs, which means less monitoring. "That brings down the cost significantly, it means fewer MRI scans, so that would surely mean it would get Nice approval.' Early signs of dementia It's not unusual for your memory to lapse a bit as you get older. But dementia is different from 'just getting old' as it will cause noticeable - rather than gradual - changes to mental abilities and make managing everyday tasks and activities increasingly difficult. The symptoms of dementia may be small to start with, but get worse over time. Below are some examples of possible signs. Memory loss Memory loss is a key sign of dementia. This can include: Forgetting something you were only recently told. You may ask for the same information repeatedly – for example, 'Are the doors locked?' Putting objects in unusual places – for example, putting your house keys in the refrigerator. Being unable to learn new tasks, like how to use a new washing machine. Planning and decision making issues People with dementia can have difficulty with planning and decision making. This can include: Getting very confused when planning or thinking things through. Struggling to stay focused on a single task. Not making informed, careful decisions when dealing with money or looking at risks. Finding it hard to manage regular payments, budgets or monthly bills. Problems with language and understanding In people with dementia, this can manifest as: Having frequent problems finding the right word or regularly referring to objects as 'that thing'. Finding it hard to take part in conversations. Regularly being unable to follow what someone is saying even without distractions. Losing sense of time and place Dementia can cause problems with orientation, including: Losing track of the date, season or the passage of time. Getting lost in a place that is familiar or that should be easy to find your way around – for example, a supermarket. Regularly being unable to follow what someone is saying even without distractions. Problems with vision and perception This can mean having problems making sense of what you see. For example, having difficulty judging distances on stairs, or mistaking reflections or patterns for other objects. Mood and behavioural changes Finally, dementia can also make people act differently or shift their mood. This can mean: Becoming withdrawn and losing interest in work, friends or hobbies. Feeling unusually sad, anxious, frightened or low in confidence. Getting easily upset at home, at work, with friends or in places that usually feel comfortable or familiar. Source: Alzheimer's Society Trials for lecanemab and donanemab showed the drugs helped clear toxic clumps out of the brain and slow nerve damage caused by Alzheimer's by 27 per cent and 35 per cent respectively, over the course of 18 months. But the treatments did present a risk of brain swelling and brain bleeds, meaning patients needed intense monitoring. Trontinemab appears to be safer and cause fewer side effects, with less than five per cent of patients showing abnormal results on their brain scans. All of these cases were quickly resolved, researchers said. The drug - administered by infusion into the bloodstream - also doesn't need to be given a frequently. Upcoming trials will examine the impact of giving the drug to patients once a month for six months, then every three months. Trontinemab has been designed to efficiently bypass the blood-brain barrier, a protective layer of cells that stops harmful substances in the blood stream from attacking the brain and spinal cord. This barrier can make it hard for many drugs to reach the brain. Prof Jonathan Schott, the chief medical officer at Alzheimer's Research UK, told the Telegraph: 'We urgently need a range of treatments for Alzheimer's that are effective and safe for the people affected by this devastating disease. 'Evidence presented at the Alzheimer's Association conference in Toronto on trontinemab is very promising, showing that the drug can effectively and rapidly clear amyloid from the brain, seemingly with very few side effects. 'We now need to see whether these early stage results carry through to later stage clinical trials, which are planned to start later this year, including in the UK. "These trials will show whether the drug is not only safe, but impacts on memory, thinking and quality of life.' He said it was 'exciting' that the drug would now be tested in some people without symptoms under the phase three trials.

Zapping the brain could improve fitness without having to do any exercise
Zapping the brain could improve fitness without having to do any exercise

Scottish Sun

time17 hours ago

  • Scottish Sun

Zapping the brain could improve fitness without having to do any exercise

The findings also indicate out-of-shape people could work up to regular activity with the gadget's help HEART FIX Zapping the brain could improve fitness without having to do any exercise Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) ZAPPING the brain could improve fitness without people having to lift a finger, research suggests. Electrical stimulation for just 30 minutes a day for a week was found to boost heart and lung performance in tests. Sign up for Scottish Sun newsletter Sign up In the trial on 28 people, a device on the ear was used to stimulate the vagus nerve. It helps to control bodily processes such as the heartbeat, breathing and digestion. After a week, participants saw increases in their oxygen uptake. It also boosted the maximum breathing rate by an average of four breaths per minute, and maximum heart rate by four beats per minute during exercise. Blood tests also suggested lower levels of harmful inflammation. The findings also indicate out-of-shape people could work up to regular activity with the gadget's help. Study author Prof Gareth Ackland of Queen Mary University said: 'Inc­reased vagus nerve activity can improve fitness and reduce inflammation.' The trial in London was funded by the British Heart Foundation. Its chief scientific and medical officer Prof Bryan Williams added: 'This may one day be used to improve well-being for people with heart failure.' GP-approved tips to really lose weight safely - and keep it off 1 Zapping the brain could improve fitness without having to do any exercise Unlock even more award-winning articles as The Sun launches brand new membership programme - Sun Club.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store